Loading...

Proteomics International Laboratories Limited

PIQ.AXASX
Healthcare
Biotechnology
A$0.36
A$0.00(0.00%)

Proteomics International Laboratories Limited (PIQ.AX) Company Profile & Overview

Explore Proteomics International Laboratories Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Proteomics International Laboratories Limited (PIQ.AX) Company Profile & Overview

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. Proteomics International Laboratories Ltd has a research agreement with the Busselton Population Medical Research Institute and the Janssen Research & Development for the research of diabetic kidney disease treatment; and partnership with QIMR Berghofer Medical Research Institute for the detection of oesophageal adenocarcinoma. The company was founded in 2001 and is based in Perth, Australia.

SectorHealthcare
IndustryBiotechnology
CEORichard John Lipscombe MA (Oxford), (London)

Contact Information

61 8 9389 1992
QEII Medical Centre, Perth, WA, 6009

Company Facts

IPO DateApr 16, 2015
CountryAU
Actively Trading

Frequently Asked Questions

;